Cargando…

Regarding human cytomegalovirus in neuroblastoma

Detalles Bibliográficos
Autores principales:	Forslund, Ola, Holmquist Mengelbier, Linda, Gisselsson, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303172/ https://www.ncbi.nlm.nih.gov/pubmed/24740962 http://dx.doi.org/10.1002/cam4.243

Ejemplares similares

Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
por: Rastegar, Bahar, et al.
Publicado: (2023)

Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression
por: Karlsson, Jenny, et al.
Publicado: (2016)

Retinoic acid promotes differentiation of WiT49‐ but not of CCG99‐11 Wilms tumour cells
por: Jansson, Caroline, et al.
Publicado: (2023)

The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis
por: Holmquist Mengelbier, Linda, et al.
Publicado: (2018)

Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis
por: Susan Amirian, E., et al.
Publicado: (2013)

TRIM proteins in neuroblastoma
por: Xu, Yonghu, et al.
Publicado: (2019)

Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017)

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
por: Braekeveldt, Noémie, et al.
Publicado: (2015)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

Sorafenib treatment in children with relapsed and refractory neuroblastoma: an experience of four cases
por: Okada, Keiko, et al.
Publicado: (2016)

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
por: Imaya, Masayuki, et al.
Publicado: (2022)

Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?
por: Valind, Anders, et al.
Publicado: (2021)

Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma
por: Su, Yan, et al.
Publicado: (2019)

Association of image‐defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma
por: Temple, William C., et al.
Publicado: (2020)

Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis
por: Kitagawa, Koichi, et al.
Publicado: (2021)

Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients
por: Gattolliat, Charles-Henry, et al.
Publicado: (2014)

Plasma cell‐free DNA quantification is highly correlated to tumor burden in children with neuroblastoma
por: Wang, Xisi, et al.
Publicado: (2018)

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
por: Costa, Ana, et al.
Publicado: (2022)

Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas
por: Gisselsson, David, et al.
Publicado: (2007)

MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children
por: Jiang, Susu, et al.
Publicado: (2023)

A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis
por: Kreitz, Kiana, et al.
Publicado: (2019)

MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma
por: Yue, Zhi‐Xia, et al.
Publicado: (2022)

The immune cell atlas of human neuroblastoma
por: Verhoeven, Bronte Manouk, et al.
Publicado: (2022)

Detection of tumor ALK status in neuroblastoma patients using peripheral blood
por: Combaret, Valérie, et al.
Publicado: (2015)

TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case–control study
por: Fang, Yuan, et al.
Publicado: (2020)

Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
por: Saulnier Sholler, Giselle L, et al.
Publicado: (2015)

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2017)

IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models
por: Stip, Marjolein C, et al.
Publicado: (2023)

Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma
por: Meng, Xinyao, et al.
Publicado: (2020)

Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity
por: Altinoz, Meric A., et al.
Publicado: (2020)

Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
por: Wang, Hui Qin, et al.
Publicado: (2017)

Unsolved problems and concluding recommendations regarding cytomegalovirus.
por: Ho, M., et al.
Publicado: (1976)

Anti-tumor effects of rigosertib in high-risk neuroblastoma
por: Radke, Katarzyna, et al.
Publicado: (2021)

Genetic variation associated with childhood and adult stature and risk of MYCN‐amplified neuroblastoma
por: Semmes, Eleanor C., et al.
Publicado: (2020)

A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma
por: Cai, Ling, et al.
Publicado: (2023)

GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
por: Pascual-Pasto, Guillem, et al.
Publicado: (2022)

Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis
por: Zhao, Chunyan, et al.
Publicado: (2021)

Intratumour Diversity of Chromosome Copy Numbers in Neuroblastoma Mediated by On-Going Chromosome Loss from a Polyploid State
por: Lundberg, Gisela, et al.
Publicado: (2013)

Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma
por: Kawano, Kumi, et al.
Publicado: (2013)

Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3‐induced mitophagy
por: Lee, Wen‐Jui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mv5kiek7rghor82cin99udinsu